Combined Thymoglobulin and Interleukin-2 Receptor Antagonist Induction Therapy in Kidney Transplantation Is Associated With Worse Delayed Graft Function, Acute Rejection, Graft Loss, and Mortality

Authors

• Macrae Kozody
• Jorge Ortiz, Touro College of Osteopathic MedicineFollow
• Yang Yu
• Arnav Bhalla
• Hamsini Katasani
• Kyle Herdrich
• Meng-Hao Li
• Naoru Koizumi
• Geovani Faddoul

Roles

Author

Document Type

Article

Publication Date

1-1-2025

Publication Title

Journal of Surgical Research

DOI

10.1016/j.jss.2025.04.026

Recommended Citation

Kozody, M., Ortiz, J., Yu, Y., Bhalla, A., Katasani, H., Herdrich, K., Li, M., Koizumi, N., & Faddoul, G. (2025). Combined Thymoglobulin and Interleukin-2 Receptor Antagonist Induction Therapy in Kidney Transplantation Is Associated With Worse Delayed Graft Function, Acute Rejection, Graft Loss, and Mortality. Journal of Surgical Research, 311, 203-211. https://doi.org/10.1016/j.jss.2025.04.026